Warning! The directory is not yet complete and will be amended until the beginning of the term.
270041 VO Medical Radiochemistry II (2025S)
Tracer Development - from Bench to Bed
Labels
Die Vorlesung findet mittwochs 16:30 bis 18:00 in der Bibliothek der Nuklearmedizin am AKH, Ebene 3L, Währinger Gürtel 18-20, 1090 Wien statt.
5.3.
12.3.
19.3.
26.3.
2.4.
9.4.
30.4.
7.5.
14.5.
21.5.
28.5.
5.3.
12.3.
19.3.
26.3.
2.4.
9.4.
30.4.
7.5.
14.5.
21.5.
28.5.
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
Details
Language: German
Lecturers
Classes
Die Vorlesung findet mittwochs 16:30 bis 18:00 in der Bibliothek der Nuklearmedizin am AKH, Ebene 3L, Währinger Gürtel 18-20, 1090 Wien statt.
5.3.
12.3.
19.3.
26.3.
2.4.
9.4.
30.4.
7.5.
14.5.
21.5.
28.5.
Information
Aims, contents and method of the course
Assessment and permitted materials
Multiple Choice Test (written/online), teaching material permitted3 Dates (13.06.22 & 29.06.22 & 26.09)
Minimum requirements and assessment criteria
>50% correct answers to pass exam
-To learn about the most important pharmacological criteria in radiopharmaceutical drug development
-To know the most important radiopharmaceuticals for nuclear medicine
-To hear about important methods in drug development
-To understand essentials in (radio)pharmacological behavior
-To understand the theranostic concept
-To understand preclinical and clinical study designs (development process)
-To learn about the most important pharmacological criteria in radiopharmaceutical drug development
-To know the most important radiopharmaceuticals for nuclear medicine
-To hear about important methods in drug development
-To understand essentials in (radio)pharmacological behavior
-To understand the theranostic concept
-To understand preclinical and clinical study designs (development process)
Examination topics
See above, minimum requirements and assessment criteria
Reading list
1. "Handbook of Radiopharmaceuticals" von Michael Welch und Carol S. Redvanly
2. "Radiopharmaceuticals: in Nuclear Pharmacy and Nuclear Medicine" von Richard J., Ph.D. Kowalsky, Steven W., Ph.D. Falen
3. . ETH ZÜRICH - RADIOPHARMAZEUTISCHE CHEMIE http://www.pharma.ethz.ch/institute_groups/radiopharmaceutical_science/lectures/index
4. Universität Würzburg - KURSUS DER NUKLEARMEDIZIN http://www.uni-wuerzbrug.de/nuklearmedizin/kursus/Kursus.htm
5. 5. The role of radiopharmaceuticals in drug discovery and development. Kairemo K. Curr Pharm Des. 2009;15(9):926-7
6. Molecular Imaging with PET. Ametamey S, Honer M, Schubiger PA, Chem. Rev. 2008, 108, 1501–1516
7. Animal Models for Human Cancer, Edited by Marianne I. Martic-Kehl and P. August Schubiger, Dicovery and Development of Novel Therapeutics, Volume 69
2. "Radiopharmaceuticals: in Nuclear Pharmacy and Nuclear Medicine" von Richard J., Ph.D. Kowalsky, Steven W., Ph.D. Falen
3. . ETH ZÜRICH - RADIOPHARMAZEUTISCHE CHEMIE http://www.pharma.ethz.ch/institute_groups/radiopharmaceutical_science/lectures/index
4. Universität Würzburg - KURSUS DER NUKLEARMEDIZIN http://www.uni-wuerzbrug.de/nuklearmedizin/kursus/Kursus.htm
5. 5. The role of radiopharmaceuticals in drug discovery and development. Kairemo K. Curr Pharm Des. 2009;15(9):926-7
6. Molecular Imaging with PET. Ametamey S, Honer M, Schubiger PA, Chem. Rev. 2008, 108, 1501–1516
7. Animal Models for Human Cancer, Edited by Marianne I. Martic-Kehl and P. August Schubiger, Dicovery and Development of Novel Therapeutics, Volume 69
Association in the course directory
CH-CBS-08, BC-Wahl
Last modified: Tu 28.01.2025 11:46
-Pharmacokinetics and Modelling
-Special Challenges in neuro-radiopharmaceutical development (blood brain barrier)
- Methods of radiopharmaceutical drug development and process
-Radiopharmaceuticals for diagnostic, therapeutic use and developments in neuroimaging
-Preclinical studies (in vitro, animal studies) and clinical studies